|Day Low/High||113.72 / 116.46|
|52 Wk Low/High||77.95 / 120.04|
The fact that three of the Kings are making dividend news this week makes it something special.
We have more than 1,050 companies reporting quarterly earnings from Monday to Friday, and here are the ones to keep focus on.
It's time for the central bank to show the same level of concern for their misplaced aggression.
These stocks offer not only terrific histories of dividend increases, but are also trading at reasonable valuations.
These names have raised their dividends for an amazing 50 years or more.
These 'recession-resistant' names have proven they can thrive in a variety of economic conditions and through changing technologies and sentiments.
The driver of these quarterly results that blew the lid off of the share price last night was the outperformance of AWS.
For my portfolio, you can't beat this SBUX competitor -- and for a cup of coffee.
You might actually be grateful that stocks took one on the jaw on Monday.
With 7 positions set to report this week, we purposely stayed on the sidelines over the last few days.
Connection to the energy industry has weighed heavily on results; the stock plunged Monday.
This morning the yield on the 10-year U.S. note climbed another three basis points to 1.76%. The yield is now 41 basis points above July levels, serving to underscore my notion that a Generational Low in Bond Yields already has occurred. Meanwhile,...
If nothing else, the beginning of earnings season should provide a bit more consistent price action.
As you all know I give a lot of thought to my Trade of the Week, as I did over the weekend, once again. We are doing well on these "Trades" recently - lets see if the skein can be continued! I am thinking that today's market rally is a bit of a ...
Industrial markets remain weak (more on this later in the day). Toward that end, Dover warns, which follows last week's lower guidance at Honeywell and PPG and adds to earnings problems in the important industrial sector.
Mylan rose after settling with the U.S. Department of Justice for $465 million over the way it overcharged Medicaid for the EpiPen.
After a miserable 2015 and, in many cases, a poor start to 2016, the group has been on a tear.
Here is how a stock like Caterpillar can jump on terrible guidance.
Oil prices still are months from recovering, but it could pay to check out beaten-up industry suppliers.